Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation

Area of Science:

• Cardiovascular Biology
• Pathophysiology
• Molecular Medicine

Background:

• Optimal vascular structure and function are vital for cardiovascular health.
• Vascular remodelling, alterations in vessel size, shape, and composition, underlies various cardiovascular pathologies.
• This remodelling involves dynamic cellular changes and inflammatory signaling within the vessel wall.

Purpose of the Study:

• To explore the cellular and molecular mechanisms driving vascular remodelling.
• To identify key molecular pathways involved in vascular remodelling.
• To evaluate these pathways for potential therapeutic targeting in cardiovascular diseases.

Main Methods:

• Analysis of dynamic changes in vascular wall cells (endothelium, smooth muscle cells, immune cells).
• Investigation of molecular pathways including growth factors, inflammatory cytokines, and signaling cascades (Rho/ROCK, MAPK, TGF-β/Smad).
• Evaluation of epigenetic regulators such as microRNAs and long noncoding RNAs.

Main Results:

• Vascular remodelling involves a complex interplay of cell proliferation, apoptosis, migration, inflammation, and extracellular matrix reorganization.
• Key molecular pathways implicated include growth factors (VEGF, PDGF), inflammatory cytokines (IL-1β, TNF-α), and signaling pathways (Rho/ROCK, MAPK, TGF-β/Smad).
• Epigenetic regulators like microRNAs and long noncoding RNAs play crucial roles in gene expression during vascular remodelling.

Conclusions:

• Vascular remodelling is a critical process in the pathology of cardiovascular diseases.
• Understanding the molecular and cellular underpinnings of vascular remodelling is essential for developing new therapeutic strategies.
• Targeting these pathways holds promise for clinical translation in treating cardiovascular conditions.